Why I Think Pfizer Is a Better Buy Than Merck & Co.

Pfizer's products and pipeline opportunity may give it an edge over Merck.

Pfizer (NYSE:PFE) and Merck & Co. (NYSE:MRK) are two of the biggest drugmakers on the planet, and both of these companies reward investors with a healthy dividend yield. But I believe it's Pfizer, not Merck, that ought to be in an investor's portfolio. 

Here's why...

Source: The Motley Fool

Forget Rising Rates. 5 Great REITs To Buy Today

Some REITs have what it takes to outperform in this sort of environment Real estate investment trusts (REITs) have really take...